Galina S. Bogatkevich

Thrombin Differentiates Normal Lung Fibroblasts to a Myofibroblast Phenotype via the Proteolytically Activated Receptor-1 and a Protein Kinase C-dependent Pathway

Galina S. Bogatkevich, Elena Tourkina, Richard M. Silver et al. · Journal of Biological Chemistry · 2001 · 197 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases

Renato G.S. Chirivi, Jos W.G. van Rosmalen, Maarten van der Linden et al. · Cellular and Molecular Immunology · 2020 · 149 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

Galina S. Bogatkevich, Paul J. Nietert, Tanjina Akter et al. · Arthritis & Rheumatism · 2011 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Identification of Gβγ Binding Sites in the Third Intracellular Loop of the M3-muscarinic Receptor and Their Role in Receptor Regulation

Guangyu Wu, Galina S. Bogatkevich, Y. Mukhin et al. · Journal of Biological Chemistry · 2000 · 101 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts

Galina S. Bogatkevich, Richard M. Silver · Arthritis & Rheumatism · 2009 · 94 citations · Full text

Life Sciences, Molecular Biology, Inflammation +14